Home monitoring with connected mobile devices for asthma attack prediction with machine learning.


Journal

Scientific data
ISSN: 2052-4463
Titre abrégé: Sci Data
Pays: England
ID NLM: 101640192

Informations de publication

Date de publication:
08 06 2023
Historique:
received: 24 10 2022
accepted: 15 05 2023
medline: 12 6 2023
pubmed: 9 6 2023
entrez: 8 6 2023
Statut: epublish

Résumé

Monitoring asthma is essential for self-management. However, traditional monitoring methods require high levels of active engagement, and some patients may find this tedious. Passive monitoring with mobile-health devices, especially when combined with machine-learning, provides an avenue to reduce management burden. Data for developing machine-learning algorithms are scarce, and gathering new data is expensive. A few datasets, such as the Asthma Mobile Health Study, are publicly available, but they only consist of self-reported diaries and lack any objective and passively collected data. To fill this gap, we carried out a 2-phase, 7-month AAMOS-00 observational study to monitor asthma using three smart-monitoring devices (smart-peak-flow-meter/smart-inhaler/smartwatch), and daily symptom questionnaires. Combined with localised weather, pollen, and air-quality reports, we collected a rich longitudinal dataset to explore the feasibility of passive monitoring and asthma attack prediction. This valuable anonymised dataset for phase-2 of the study (device monitoring) has been made publicly available. Between June-2021 and June-2022, in the midst of UK's COVID-19 lockdowns, 22 participants across the UK provided 2,054 unique patient-days of data.

Identifiants

pubmed: 37291158
doi: 10.1038/s41597-023-02241-9
pii: 10.1038/s41597-023-02241-9
pmc: PMC10248342
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

370

Subventions

Organisme : Asthma UK
ID : AUK-AC-2018-01
Organisme : Asthma UK
ID : AUK-AC-2018-01
Organisme : Asthma UK
ID : AUK-AC-2018-01
Organisme : Asthma UK
ID : AUK-AC-2018-01

Informations de copyright

© 2023. The Author(s).

Références

JAMIA Open. 2020 May 07;3(2):190-200
pubmed: 32734159
J Telemed Telecare. 2017 Feb;23(2):248-255
pubmed: 27036878
J Allergy Clin Immunol Pract. 2020 Jun;8(6):1972-1979.e8
pubmed: 32142961
Eur Respir J. 1999 Oct;14(4):902-7
pubmed: 10573240
BMC Med. 2017 Mar 17;15(1):64
pubmed: 28302126
BMJ Open. 2022 Oct 3;12(10):e064166
pubmed: 36192103
Respir Res. 2005 Oct 21;6:120
pubmed: 16242029
BMJ Open. 2017 Jan 24;7(1):e013935
pubmed: 28119390
Curr Allergy Asthma Rep. 2015 Jun;15(6):28
pubmed: 26141573
Prim Care Respir J. 2012 Sep;21(3):288-94
pubmed: 22751737
BMJ. 2009 Aug 11;339:b2803
pubmed: 19671932
Heart. 2018 Jul;104(13):1048-1049
pubmed: 29382691
Environ Health Perspect. 2017 Feb;125(2):254-261
pubmed: 27340894
Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:5673-5677
pubmed: 33019264
BMJ. 1989 Apr 22;298(6680):1068-70
pubmed: 2497892
Sci Data. 2018 May 22;5:180096
pubmed: 29786695
Lancet Reg Health Eur. 2022 Aug;19:100428
pubmed: 35756853
JMIR Mhealth Uhealth. 2016 Jun 10;4(2):e72
pubmed: 27287964
J Allergy Clin Immunol Pract. 2022 Feb;10(2):495-505.e2
pubmed: 34626858
Front Pediatr. 2019 Jun 25;7:256
pubmed: 31294006
Am J Respir Crit Care Med. 2009 Jul 1;180(1):59-99
pubmed: 19535666
J Asthma Allergy. 2022 Jun 29;15:855-873
pubmed: 35791395
BMC Pulm Med. 2019 Apr 8;19(1):74
pubmed: 30961573
BMJ. 2010 Jan 28;340:c181
pubmed: 20110312
Nat Biotechnol. 2017 Apr;35(4):354-362
pubmed: 28288104

Auteurs

Kevin C H Tsang (KCH)

Asthma UK Centre for Applied Research, Usher Institute, University of Edinburgh, Edinburgh, UK. kevin.tsang@ed.ac.uk.
Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK. kevin.tsang@ed.ac.uk.

Hilary Pinnock (H)

Asthma UK Centre for Applied Research, Usher Institute, University of Edinburgh, Edinburgh, UK.

Andrew M Wilson (AM)

Asthma UK Centre for Applied Research, Usher Institute, University of Edinburgh, Edinburgh, UK.
Norwich Medical School, University of East Anglia, Norwich, UK.
Norwich University Hospital Foundation Trust, Colney Lane, Norwich, UK.

Dario Salvi (D)

Internet of Things and People Research Centre, Malmö University, Malmö, Sweden.

Syed Ahmar Shah (SA)

Asthma UK Centre for Applied Research, Usher Institute, University of Edinburgh, Edinburgh, UK. ahmar.shah@ed.ac.uk.
Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK. ahmar.shah@ed.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH